Army of Women FAQ
Have questions about how the Army of Women works? We've got the answers you're looking for in our FAQs.
Current Projects
Project Title Combination of Low-Dose Anti-Estrogens with Omega-3 Fatty Acids for Prevention of Hormone-Independent Breast Cancer
Researcher Andrea Manni, MD, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania
Study Summary The purpose of this study is to find out if combining raloxifene with a dietary supplement called omega-3 fatty acid has an effect on breast density or urine and blood chemicals associated with breast cancer development.
Who Can Participate? You can join the Raloxifene and Omega-3 Fatty Acid Study if you match ALL of these MAIN categories:
• You are post-menopausal (at least 12 months without a menstrual cycle)
• You have never had breast cancer
• You are not on hormone replacement therapy
• You are a non-smoker (never smoked or smoke free for more than 5 years)
• You are a woman between the ages of 35 and 75
• You live near or are willing to travel to the Penn State Milton S. Hershey Medical Center in Hershey, PA
The researcher may ask you additional questions to be sure that this study is a right fit for you.
What Does Participation Involve? If you express interest in the raloxifene and Omega-3 Fatty Acid Study, you need to have your next mammogram at the Breast Care Center at the Hershey Medical Center. You will be given a health-screening questionnaire so that the researchers can be sure this study is a right fit for you. After that, your mammogram will be reviewed, and if your density is read as greater than 25%, you could be eligible to participate in the study. After you sign the informed consent, you will be asked to complete a diet history and exercise questionnaire. Then, approximately eight tablespoons of blood will be collected and you will be asked to collect your first morning urine for three consecutive days. Finally, you will be randomly assigned to either a group taking no treatment or to one of four other groups which include Raloxifene at 60 mg or 30 mg, or just omega-3 fatty acid or a combination of the lower dose of Raloxifene and omega-3 fatty acid. Over the course of the study, you will meet with the research team every six months for two years.
The researchers will discuss all study procedures, any possible risk factors, and answer all questions you may have.
Approximately 372 women are needed for this study.
Where? Penn State Milton S. Hershey Medical Center in Hershey, PA
Connect with the Army:
